SCHEMBL30995682

SCHEMBL30995682

COC(=O)C[C@@]1(N)CCCc2cnccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 3/20 0.38
KDM5A P29375 1/20 0.38
KDM5B Q9UGL1 1/20 0.38
LATS1 O95835 1/20 0.38
AAK1 Q2M2I8 1/20 0.35
F2 P00734 1/20 0.35
SIGMAR1 Q99720 1/20 0.34
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
GLA P06280 2/20 0.34
GAA P10253 2/20 0.34
GRM4 Q14833 1/20 0.33
CHRM2 P08172 2/20 0.33
CHRM3 P20309 2/20 0.33
CHRM1 P11229 1/20 0.33
CYP19A1 P11511 1/20 0.33
ROCK2 O75116 1/20 0.32
GRK2 P25098 1/20 0.32
CYP11B2 P19099 1/20 0.32
NLRP3 Q96P20 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28476884 1.00 KDM4C (0.38) KDM4CKDM5AKDM5BLATS1AAK1
SCHEMBL28476883 1.00 KDM4C (0.38) KDM4CKDM5AKDM5BLATS1AAK1
SCHEMBL30995685 0.90 KDM4C (0.40) KDM4CKDM5AKDM5BLATS1AAK1
SCHEMBL28486636 0.90 KDM4C (0.40) KDM4CKDM5AKDM5BLATS1AAK1
SCHEMBL28486638 0.90 KDM4C (0.40) KDM4CKDM5AKDM5BLATS1AAK1
SCHEMBL28483551 0.84 KDM4C (0.38) KDM4CKDM5AKDM5BF2SIGMAR1
SCHEMBL20137432 0.84 KDM4C (0.38) KDM4CKDM5AKDM5BF2SIGMAR1
SCHEMBL20137431 0.82 KMT2A (0.47) KDM4CKDM5AKDM5B
SCHEMBL30995679 0.82 KMT2A (0.47) KDM4CKDM5AKDM5B
SCHEMBL20137430 0.82 KMT2A (0.47) KDM4CKDM5AKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12006323-B2 Ethynyl derivatives HOFFMANN-LA ROCHE INC. (US) 2024-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12006323-B2 Ethynyl derivatives GRM4, GRM2, GRIA4 KDM4C 3493/4885KDM5A 3934/4885KDM5B 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.